Skip to content

NYSE · CIK 0001453593

XTNT Xtant Medical Holdings, Inc.

Insider trading from SEC Form 4. Last filing Feb 18, 2026. Close $0.33 on Oct 9, 2026, +6% from the 52-week low and -64% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company

Price and insider trades, last year

XTNTOct 9, 2026 · close 0.33

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Xtant Medical Holdings, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
57ModerateOrbimed Advisors LLC
owner
sell
$31M
73,114,592 shares
-131%-

Transactions

The last 19 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Feb 15, 2026Mark A. Schallenberger
Chief Operating Officer
FTax withholding
Common Stock
-7,709$0.58$4,471663,157Feb 18, 2026
Jan 15, 2026Scott C Neils
CFO and Assistant Secretary
FTax withholding
Common Stock
-8,084$0.65$5,255843,381Jan 16, 2026
Nov 15, 2025John K Bakewell
director
AGrant or award
Common Stock
+158,228$0.00$0158,228Nov 18, 2025
Nov 15, 2025Jonn R. Beeson
director
AGrant or award
Common Stock
+158,228$0.00$0517,619Nov 18, 2025
Nov 15, 2025Sean E Browne
President and CEO
AGrant or award
Common Stock
+394,937$0.00$02,575,274Nov 18, 2025
Nov 15, 2025John K Bakewell
director
AGrant or award
Common Stock
+158,228$0.00$0914,116Nov 18, 2025
Nov 15, 2025Abhinav Jain
director
AGrant or award
Common Stock
+158,228$0.00$0158,228Nov 18, 2025
Nov 15, 2025Tyler Lipschultz
director
AGrant or award
Common Stock
+158,228$0.00$0158,228Nov 18, 2025
Nov 15, 2025Scott C Neils
CFO and Assistant Secretary
AGrant or award
Common Stock
+263,291$0.00$0851,465Nov 18, 2025
Nov 15, 2025Mark A. Schallenberger
Chief Operating Officer
AGrant or award
Common Stock
+292,253$0.00$0670,866Nov 18, 2025
Nov 15, 2025Stavros G. Vizirgianakis
director
AGrant or award
Common Stock
+553,797$0.00$07,515,570Nov 18, 2025
Nov 15, 2025Scott C Neils
CFO and Assistant Secretary
AGrant or award
Performance Stock Units (PSUs)derivative
+526,582$0.00$0526,582Nov 18, 2025
Nov 15, 2025Mark A. Schallenberger
Chief Operating Officer
AGrant or award
Performance Stock Units (PSUs)derivative
+584,506$0.00$0584,506Nov 18, 2025
Nov 15, 2025Sean E Browne
President and CEO
AGrant or award
Performance Stock Units (PSUs)derivative
+789,874$0.00$0789,874Nov 18, 2025
Aug 15, 2025Sean E Browne
President and CEO
FTax withholding
Common Stock
-10,605$0.63$6,6812,180,337Aug 19, 2025
Aug 15, 2025Scott C Neils
CFO
FTax withholding
Common Stock
-34,131$0.63$22k588,174Aug 19, 2025
Apr 10, 2025Orbimed Advisors LLC
owner
SOpen-market sale
Common Stockindirect: See footnotes
-56,004,974$0.42$24M0Apr 14, 2025
Apr 10, 2025Orbimed Advisors LLC
owner
SOpen-market sale
Common Stockindirect: See footnotes
-17,109,618$0.42$7.2M0Apr 14, 2025
Oct 15, 2024Sean E Browne
President and CEO
FTax withholding
Common Stock
-105,442$0.59$62k2,190,942Oct 16, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.